BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31880209)

  • 1. Prognostic value of
    Choi EK; Park M; Im JJ; Chung YA; Oh JK
    J Int Med Res; 2020 Apr; 48(4):300060519892419. PubMed ID: 31880209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
    Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M
    Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
    Ding CY; Guo Z; Li YY; Li TR
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
    Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of metabolic parameters measured by
    Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW
    J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of PET/CT in small-cell lung cancer.
    Budak E; Yanarateş A; Akgün A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):9-13. PubMed ID: 31865009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.
    Oh JR; Seo JH; Chong A; Min JJ; Song HC; Kim YC; Bom HS
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):925-35. PubMed ID: 22270509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
    Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of metabolic parameters measured by
    Mathew B; Purandare NC; Puranik A; Shah S; Agrawal A; Pramesh CS; Karimundackal G; Jiwnani S; Rangarajan V
    World J Nucl Med; 2020; 19(1):8-14. PubMed ID: 32190016
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.
    Mayoral M; Fernandez-Martinez A; Vidal L; Fuster D; Aya F; Pavia J; Pons F; Lomeña F; Paredes P
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):88-95. PubMed ID: 26541072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer.
    Kwon SH; Hyun SH; Yoon JK; An YS; Oh YT; Choi JH; Park KJ; Lee SJ
    Medicine (Baltimore); 2016 Feb; 95(5):e2772. PubMed ID: 26844524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma.
    Xia J; Zhu HY; Liang JH; Ding CY; Wang L; Wu W; Cao L; Li TL; Li JY; Xu W
    J Cancer; 2019; 10(23):5805-5811. PubMed ID: 31737117
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
    Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J
    Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary tumor SUV
    Tas F; Ozturk A; Erturk K
    Wien Klin Wochenschr; 2023 Sep; 135(17-18):478-487. PubMed ID: 36882606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio between the whole-body and primary tumor burden, measured on
    Oliveira FRA; Santos AO; de Lima MDCL; Toro IFC; de Souza TF; Amorim BJ; Barbeiro AS; Etchebehere E
    Radiol Bras; 2021; 54(5):289-294. PubMed ID: 34602663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
    Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ
    Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer.
    Park SB; Choi JY; Moon SH; Yoo J; Kim H; Ahn YC; Ahn MJ; Park K; Kim BT
    Cancer Imaging; 2014 Apr; 14(1):2. PubMed ID: 25609313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
    Oh JR; Seo JH; Hong CM; Jeong SY; Lee SW; Lee J; Min JJ; Song HC; Bom HS; Kim YC; Ahn BC
    Lung Cancer; 2013 Aug; 81(2):218-25. PubMed ID: 23731740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.